Vyripharm Biopharmaceuticals

Vyripharm Biopharmaceuticals is a biopharmaceutical company focused on neurological disorders and cancer. It offers BioSync, a platform that integrates agribiopharmaceuticals/biotechnology and biopharmaceutical/biotechnology data acquisition and management. Vyripharm Biopharmaceuticalsworks in sectors such as regulatory testing, pharmaceutical and diagnostic drugs, bioinformatics, medical informatics, monitoring technology, and drug delivery systems.

TypeSubsidiary
HQHouston, TX, US
Founded2014
Websitevyripharmbio.com
Cybersecurity ratingAMore
Vyripharm Biopharmaceuticals was founded in 2014 and is headquartered in Houston, TX, US

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Vyripharm Biopharmaceuticals

Elias Jackson

Elias Jackson

President of Research and Development
Eddie Patton

Eddie Patton

Chief Medical Officer
Phil Clarke

Phil Clarke

Chief Business Officer
Show more

Vyripharm Biopharmaceuticals Office Locations

Vyripharm Biopharmaceuticals has an office in Houston
Houston, TX, US (HQ)
2450 Holcombe Blvd
Show all (1)

Vyripharm Biopharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2014

Vyripharm Biopharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Vyripharm Biopharmaceuticals Online and Social Media Presence

Embed Graph

Vyripharm Biopharmaceuticals News and Updates

Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off on a Master Drug Program Agreement for Expediting cGMP Manufacture of Our Antiviral Agents for Diagnostic Evaluation of COVID-19

Vyripharm Biopharmaceuticals, a subsidiary of Vyripharm Enterprises, LLC, a privately held company located in the Texas Medical Center in Houston, Texas, announced today that it has signed off on a Master Drug Program Agreement with Regis Technologies, Inc. Regis is a privately held contract develop…

Vyripharm Biopharmaceuticals Is in the Development Stage of a Novel Integrated Theranostic Approach for the Treatment of Viral Infections Such as COVID-19

Vyripharm Biopharmaceuticals, a subsidiary of Vyripharm Enterprises, LLC, which is a privately held company located in the Texas Medical Center in Houston Texas, announced today that it will repurpose the development of a novel theranostic platform for the diagnosis, monitoring and treatment of vira…

Vyripharm Biopharmaceuticals Frequently Asked Questions

  • When was Vyripharm Biopharmaceuticals founded?

    Vyripharm Biopharmaceuticals was founded in 2014.

  • Who are Vyripharm Biopharmaceuticals key executives?

    Vyripharm Biopharmaceuticals's key executives are Elias Jackson, Eddie Patton and Phil Clarke.

  • How many employees does Vyripharm Biopharmaceuticals have?

    Vyripharm Biopharmaceuticals has 3 employees.

  • Who are Vyripharm Biopharmaceuticals competitors?

    Competitors of Vyripharm Biopharmaceuticals include ActivX Biosciences, Qu Biologics and Turnstone Biologics.

  • Where is Vyripharm Biopharmaceuticals headquarters?

    Vyripharm Biopharmaceuticals headquarters is located at 2450 Holcombe Blvd, Houston.

  • Where are Vyripharm Biopharmaceuticals offices?

    Vyripharm Biopharmaceuticals has an office in Houston.

  • How many offices does Vyripharm Biopharmaceuticals have?

    Vyripharm Biopharmaceuticals has 1 office.